Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer

Open access

Abstract

The ligands for programmed cell death 1 (PD-1), an immunoinhibitory receptor belonging to CD28/cytotoxic T lymphocyte antigen 4 family, are PD-1 ligand 1 and 2 (PD-Ls). Recent reports suggest that the aberrant expression of PD-Ls on tumor cells impairs antitumor immunity, resulting in the immune evasion of the tumor cells. Although an inverse correlation between the expression level of PD-Ls and patients' prognosis has been reported for several malignant tumors, the follow-up period was limited because of the lack of the antibody (Ab) applicable to paraffin-embedded specimens. Here we generated a new Ab against PD-1 ligand 1 (PD-L1) and analyzed the expression level of PD-Ls in human ovarian cancer using paraffin-embedded specimens. Patients with higher expression of PD-L1 had a significantly poorer prognosis than patients with lower expression. Although patients with higher expression of PD-1 ligand 2 also had a poorer prognosis, the difference was not statistically significant. A significant inverse correlation was observed between PD-L1 expression and the intraepithelial CD8(+) T lymphocyte count, suggesting that PD-L1 on tumor cells directly suppresses antitumor CD8(+) T cells. Multivariate analysis showed the expression of PD-L1 on tumor cells and intraepithelial CD8(+) T lymphocyte count are independent prognostic factors. The PD-1/PD-L pathway can be a good target for restoring antitumor immunity in ovarian cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0611533104

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 6

  1. WP McGuire, WJ Hoskins, MF Brady, PR Kucera, EE Partridge, KY Look, DL Clarke-Pearson, M Davidson Semin Oncol 23, 40–47 (1996).
  2. Y Naito, K Saito, K Shiiba, A Ohuchi, K Saigenji, H Nagura, H Ohtani Cancer Res 58, 3491–3494 (1998).
  3. K Schumacher, W Haensch, C Roefzaad, PM Schlag Cancer Res 61, 3932–3936 (2001).
  4. O Nakano, M Sato, Y Naito, K Suzuki, S Orikasa, M Aizawa, Y Suzuki, I Shintaku, H Nagura, H Ohtani Cancer Res 61, 5132–5136 (2001).
  5. SE Strome, H Dong, H Tamura, SG Voss, DB Flies, K Tamada, D Salomao, J Cheville, F Hirano, W Lin, et al. Cancer Res 63, 6501–6505 (2003).
  6. S Wintterle, B Schreiner, M Mitsdoerffer, D Schneider, L Chen, R Meyermann, M Weller, H Wiendl Cancer Res 63, 7462–7467 (2003).

Cited by

See all 1,378

Metadata

Authors
Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., Honjo, T., & Fujii, S.
Affiliations
  • Kyoto University (JP)
  • Department of Immunology and Cell Biology, Graduate School of Biostudies, and
Venue
Proceedings of the National Academy of Sciences
Published
2007-02-27
Volume
104
Issue
9
Pages
3360-3365
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2136313650
Cited by
1,378
References
47
Citations by year
2026: 26 · 2025: 30 · 2024: 56 · 2023: 64 · 2022: 84 · 2021: 90 · 2020: 104 · 2019: 119 · 2018: 121 · 2017: 126 · 2016: 125 · 2015: 100 · 2014: 78 · 2013: 62 · 2012: 47
FWCI
16.99
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
PD-L1, PD-L2, PD-1, ovarian cancer, CD8+ T cells, tumor-infiltrating lymphocytes, prognostic factors, tumor immune evasion, antitumor immunity, paraffin-embedded tissue, PD-L1 inhibitors, tumor suppressor
MeSH terms
Adult, Aged, Antibodies, Female, Humans, Immunohistochemistry, Middle Aged, Ovarian Neoplasms, Prognosis, Antigens, CD, Multivariate Analysis, CD8-Positive T-Lymphocytes, Lymphocyte Count, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer. https://app.cochat.ai/papers/10.1073/pnas.0611533104
The paper
Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., Honjo, T., & Fujii, S. (2007). Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0611533104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.